Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

Abstract In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We compared the efficacy of auto-HCT vs. CAR-T in patients with DLBCL in a...

Full description

Bibliographic Details
Main Authors: Mazyar Shadman, Kwang W. Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M. Hossain, Peter Riedell, Ajay K. Gopal, Natalie Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid Merryman, Aleksandr Lazaryan, Ron Ram, Mark Hertzberg, Bipin Savani, Farrukh Awan, Farhad Khimani, Sairah Ahmed, Vaishalee P. Kenkre, Matthew Ulrickson, Nirav Shah, Mohamed A. Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Format: Article
Language:English
Published: Nature Publishing Group 2024-07-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-024-01084-w

Internet

https://doi.org/10.1038/s41408-024-01084-w

Similar Items